跳至主要内容
临床试验/DRKS00026660
DRKS00026660招募中不适用

Retrospective evaluation of image-guided interventional treatments of venous and arteriovenous malformations of the face - venous and arteriovenous malformations of the face

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 20 人开始时间: 2023年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
4 Years 至 one(—)
性别
All

入选标准

  • Patients diagnosed with lymphatic, arteriovenous or venous malformation of the face and having undergone image-guided treatment by sclerotherapy or embolization in the form of one or more sessions in the period from 01/01/2017 to 12/30/2021.
  • - Patients who have received the above procedures with the following sclerotherapy/embolization agents: Polidocanol, (gelled) alcohol, EVOH-based liquid embolization agents (EVOH = ethylene vinyl alcohol copolymer), bleomycin, OK 432 (picibanil), doxycycline, STS (sodium tetradecyl sulfate).

排除标准

  • - Patients with lymphatic, arteriovenous or venous malformation without facial involvement.
  • - Patients who have received other image-guided interventional procedures, e.g., electrosclerotherapy

研究者

发起方
Klinikum der Universität München, Campus Großhadern

相似试验